Trial intelligence / Profile preview

Combined NBUVB and systemic simvastatin versus NBUVB alone in vitiligo

IRCT20191013045092N2Phase 3Completed

Sponsor
Shiraz University of Medical Sciences
Start
Oct 2015
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised trial of simvastatin in Vitiligo (2 arms), sponsored by Shiraz University of Medical Sciences. Started Oct 2015; status: completed.

02

Drugs

simvastatin
03

Conditions

Vitiligo

Beyond the preview

Go deeper on IRCT20191013045092N2.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT20191013045092N2.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call